COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO
Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO. Dupixent deviendrait la première thérapie ciblée pour la BPCO en Europe -
COMMUNIQUÉ DE PRESSE
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
European Medicines Agency's CHMP recommends Dupixent for EU approval to treat uncontrolled COPD with raised blood eosinophils. If approved, it would be the first targeted therapy for COPD in the EU -
-
-
-
COMMUNIQUÉ DE PRESSE
Lalique Group announces tender offer by Silvio Denz and intends to delist from the stock exchange Offer prospectus published today; offer period begins on 17 June 2024
Lalique Group announces tender offer by Silvio Denz and intention to delist from stock exchange for strategic focus. Board recommends the offer. CEO highlights long-term vision for growth -
COMMUNIQUÉ DE PRESSE
Lalique Group annonce une offre publique d’achat de Silvio Denz et envisage de se retirer de la Bourse Publication du prospectus d’offre ce jour – Ouverture de l’offre le 17 juin 2024
Lalique Group annonce une offre publique d'achat de Silvio Denz et envisage de se retirer de la Bourse. Silvio Denz propose une prime avantageuse aux actionnaires minoritaires de Lalique Group -
-
COMMUNIQUÉ DE PRESSE
Cydar Medical Enters Into a Strategic Alliance With MarinHealth to Enhance Endovascular Aortic Care Using Cutting-Edge Artificial Intelligence (AI) Technology
Cydar Medical announces strategic alliance with MarinHealth to implement Cydar Maps, an AI-based solution enhancing surgical visualization and decision-making in minimally invasive endovascular surgeries
